Clinical Trial Update: Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an early-phase study of ARO-MAPT-SC in healthy subjects and individuals with early-onset Alzheimer's disease, currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Early Onset

Drugs mentioned

• ARO-MAPT-SC

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Alzheimer Disease, Alzheimer Disease, Early Onset | Phase 1, Phase 2 | Status: RECRUITING